Massive Bio Expands Global Access to Clinical Trials Through AI-Powered Parameterization and Pre- Screening with OpenAI Massive Bio Expands Global Access to Clinical Trials Through AI-Powered Parameterization and Pre-Screening with OpenAI Share Through OpenAI's Impact Hours program, which supports high-impact projects designed to benefit large population areas, Massive Bio is enabling real-time trial parameterization and free pre-screening services in high-population regions. OpenAI's recent launch of ChatG ...